Horizon Europe
What sets the Ferrier Institute apart
Our research expertise
Medicinal chemistry and drug discovery
We design and synthesise novel nucleoside-based antivirals, antibacterials, and bile acid derivatives to address infectious diseases and metabolic disorders.
Contact: Team Harris
Glycobiology and carbohydrate chemistry
Our teams isolate, characterise, and modify complex polysaccharides for human health applications, and develop carbohydrate-based biopolymers and therapeutics.
Contact: Team Lamiable-Oulaidi
Rare disease research
We focus on lysosomal storage disorders such as Krabbe and Gaucher diseases, rationally designing small molecules through the enzyme transition state analysis technique.
Contact: Team Lamiable-Oulaidi
Vaccine and immunotherapy development
We create vaccine adjuvants and ionisable lipids for use in next-generation vaccines and immunotherapeutics.
Contact: Team Painter
Natural product chemistry and biosynthesis
We harness natural biosynthetic pathways and computational tools to develop valuable bioactive compounds and study protein communication networks.
Contact: Team Hinkley, Team Parker
Custom synthesis and analytical platforms
Our capabilities include bespoke synthesis, process development, and advanced analytical services, supported by in-house NMR and molecular research platforms.
Contact: Team Rendle
Infrastructure and collaboration
Ferrier operates within a flexible matrix structure, allowing us to resource projects dynamically across our six scientific teams. We offer access to:
- NZ RNA Platform
- NMR facilities
- cGMP Facility (GlycoSyn)
- Websales (GlycoFineChem).
These facilities are available to collaborators and are designed to support complex, multidisciplinary research.
Let's work together
If you're seeking a capable, innovative partner for Horizon Europe funding proposals, the Ferrier Institute offers the expertise, infrastructure, and collaborative spirit to help your project succeed. To explore partnership opportunities, please contact ferrier@vuw.ac.nz.